Supplementary Figure S3 from Drug–Drug Interaction Liabilities with BTK Inhibitor TL-895
<p>Pharmacokinetic profile of TL-895 in C57BL/6 and NSG mice. TL-895 plasma concentrations were determined in male and female mice on a C57BL/6 (A) or NSG (B) background strain. Mice received a single oral dose of 3 or 10 mg/kg. Data represent mean values (symbols) and SD (error bars) using 5 animals per group.</p>
Authors
- Mahesh R. Nepal (ORCID: https://orcid.org/0000-0001-7259-2699)
- Kevin M. Huang (ORCID: https://orcid.org/0000-0001-6561-3295)
- Eman Abd El-Mordy Elsayed Ahmed (ORCID: https://orcid.org/0000-0003-0973-2630)
- Thomas Drabison
- Daelynn R. Buelow (ORCID: https://orcid.org/0000-0002-4413-5711)
- Shelley Orwick (ORCID: https://orcid.org/0000-0002-4537-1409)
- Jack C. Stromatt (ORCID: https://orcid.org/0000-0001-8864-4617)
- Alex Sparreboom (ORCID: https://orcid.org/0000-0003-2660-6644)
- Eric D. Eisenmann (ORCID: https://orcid.org/0000-0003-1176-675X)
- Sharyn D. Baker (ORCID: https://orcid.org/0000-0003-3062-3252)
- Anika T. Chowdhury
Publication Details
- Published
- 2025-09-12
- DOI
- https://doi.org/10.1158/2767-9764.30111359
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00